Although pharmacists are key members of the healthcare team, they are currently ineligible to independently prescribe the oral coronavirus disease 2019 (COVID-19) antivirals. We report the roles pharmacists have undertaken during the COVID-19 pandemic and provide evidence for the support of independent oral COVID-19 antiviral prescribing.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726491 | PMC |
| http://dx.doi.org/10.1017/ash.2022.248 | DOI Listing |
Publication Analysis
Top Keywords
coronavirus disease
8
disease 2019
8
2019 covid-19
8
covid-19 antivirals
8
pharmacists prescribers
4
prescribers coronavirus
4
covid-19
4
antivirals pharmacists
4
pharmacists key
4
key members
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!